Bioventus Inc

BVS10 Dec 2024
Healthcare
$11.64
-0.03 (-3.42%)
Lowest Today
$11.11
Highest Today
$11.64
Today’s Open
$11.64
Prev. Close
$11.68
52 Week High
$14.38
52 Week Low
$3.9
To Invest in Bioventus Inc

Bioventus Inc

Healthcare
BVS10 Dec 2024
-0.03 (-3.42%)
1M
3M
6M
1Y
5Y
Low
$11.11
Day’s Range
High
$11.64
11.11
52 Week Low
$3.9
52-Week Range
52 Week High
$14.38
3.9
1 Day
-
1 Week
-4.83%
1 month return
-1.22%
3 month return
+11.37%
6 month return
+80.83%
1 Year return
+131.22%
3 Years return
-15.52%
5 Years return
-
10 Years return
-
Institutional Holdings
Essex Woodlands Health Ventures
19.92
Juniper Investment Co, LLC
10.62
Nantahala Capital Management, LLC
6.66
BlackRock Inc
3.63
Vanguard Group Inc
3.17
iShares Russell 2000 ETF
1.61
Morgan Stanley - Brokerage Accounts
1.54

Market Status

Fundamentals
Market Cap
763.5 mln
PB Ratio
5.13
PE Ratio
0
Enterprise Value
1104.01 mln
Total Assets
810.91 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise bone graft substitutes that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries; and ultrasonic products used for precise bone cutting and sculpting, soft tissue management, and tissue debridement, in various surgeries, including minimally invasive applications. The company's product include, Osteoamp, an allograft-derived bone graft for bone grafting procedures; Exponent matrix for posterolateral spine procedures; Purebone for bone grafting procedures; Signafuse bone graft; Interfuse bone graft; Osteomatrix+ synthetic bone graft; Extractor for autologous cell and bone marrow extraction; reficio bone matrix; nexus ultrasonic surgical system; bonescalpel surgical solution; SonaStar for surgical procedures; and SonicOne ultrasonic cleansing and debridement system. The company's restorative therapies include a bone stimulation system and devices to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. Its products include exogen, a bone healing system; L300 GO, a foot drop system; H200 rehabilitation system; Vector, a body weight support system; and Bioness integrated therapy system. It developing Talisman pulse generator and receiver for peripheral nerve stimulation. The company was founded in 2011 and is headquartered in Durham, North Carolina.
Organisation
Bioventus Inc
Employees
1030
Industry
Medical Devices
CEO
Mr. Robert E. Claypoole
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step